Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 1/2012

01-02-2012

Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods

Published in: Abdominal Radiology | Issue 1/2012

Login to get access
Metadata
Title
Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods
Publication date
01-02-2012
Published in
Abdominal Radiology / Issue 1/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9758-1

Other articles of this Issue 1/2012

Abdominal Radiology 1/2012 Go to the issue

OriginalPaper

Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results

Report

Fetus-in-fetu: imaging and pathologic findings

OriginalPaper

Contrast-enhanced ultrasound in abdominal imaging

OriginalPaper

MR findings of lithium-related kidney disease: preliminary observations in four patients

OriginalPaper

Common and unusual diseases involving the iliopsoas muscle compartment: spectrum of cross-sectional imaging findings

ReviewPaper

Whole-body MR/PET: applications in abdominal imaging

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits